early access to medicines services

We strive to connect the hope of patients with the possibility of treatments.

At CCPS, our Early Access to Medicines (EAM) services are designed with one goal in mind: to expand access to treatment so more people benefit from the impact of innovative medicines. 

Our EAM department comes from the clinical trial world and each of our team members have been part of global oncology and rare disease drug development and global clinical trialsThese skills have been transferred over to the unique world of “Early Access to Treatments”.

CCPS not only has the skills and experience to design, set up, and manage these unique programs around the world, we have demonstrated this capability with numerous companies wishing to bring their valuable treatments to patients in need.

Lynn Waltzman

“Every program is unique and so is our approach. We consider ourselves an extension of your team, and our top priority is to ensure your program operates smoothly. Our high touch, personalized approach focuses on supporting the physician. By prioritizing the physician’s need, we can positively impact the delivery of drug to appropriate patients in need.”

–Lynn Waltzman, Senior Director, Global Operations, Early Access to Medicines

20

Years of Experience in EAM Program Management

1,900+

Physician Requests for Medications Fulfilled

4,800+

Global EAM Shipments

43

Countries with EAM Requests

To find out more about our full-service model, select the services below:

RESOURCES FOR…

PHYSICIAN

LEARN MORE

PATIENT

LEARN MORE